Rhumbline Advisers TELIX PHARMACEUTICALS LTD Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
Number of Shares
1,187
Previous 1,146
3.58%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%